Lexicon Pharmaceuticals (LXRX) Amortizatization of Intangibles (2010 - 2026)
Lexicon Pharmaceuticals' (LXRX) quarterly Amortizatization of Intangibles came in at $562000.0 in Q1 2026, down 57.62% year-on-year from $1.3 million in Q1 2025, and up 27.73% on a QoQ basis from $440000.0 in Q4 2025.
Lexicon Pharmaceuticals (LXRX) Amortizatization of Intangibles (2010 - 2026) Analysis & Trends
Lexicon Pharmaceuticals (LXRX) has 5 years of Amortizatization of Intangibles data on file, last reported at $562000.0 in Q1 2026.
- On a quarterly basis, Amortizatization of Intangibles fell 57.62% year-over-year to $562000.0 in Q1 2026; TTM through Mar 2026 was $2.9 million, a 68.07% decrease from a year earlier, with the FY2025 full-year figure at $3.7 million, down 60.11% from the prior year.
- Amortizatization of Intangibles for Q1 2026 stood at $562000.0, up from $440000.0 in the prior quarter.
- Over the last five years, Amortizatization of Intangibles for LXRX reached as high as $3.3 million in Q2 2024 and fell as low as $440000.0 in Q4 2025.
- Historically, Amortizatization of Intangibles has averaged $1.6 million across 4 years, with a median of $1.4 million in 2024.
- On a YoY basis, Amortizatization of Intangibles climbed as much as 5.22% in 2025 and fell as far as 76.68% in 2025.
- Year by year, Amortizatization of Intangibles stood at $2.0 million in 2023, then retreated by 5.84% to $1.9 million in 2024, then sank by 76.68% to $440000.0 in 2025, then grew by 27.73% to $562000.0 in 2026.
- Per Business Quant data, the three most recent Amortizatization of Intangibles figures were $562000.0 in Q1 2026, $440000.0 in Q4 2025, and $732000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 3.22 Mn |
| 10 | Lexicon Pharmaceuticals | 888.49 Mn | 717.83 Mn | 20.99 Mn | 562,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 562,000.00 |
| Mar 31, 2026 | 562,000.00 |
| Dec 31, 2025 | 440,000.00 |
| Dec 31, 2025 | 440,000.00 |
| Sep 30, 2025 | 732,000.00 |
| Sep 30, 2025 | 732,000.00 |
| Jun 30, 2025 | 1.21 Mn |
| Jun 30, 2025 | 1.21 Mn |
| Mar 31, 2025 | 1.33 Mn |
| Mar 31, 2025 | 1.33 Mn |
| Dec 31, 2024 | 1.89 Mn |
| Dec 31, 2024 | 1.89 Mn |
| Sep 30, 2024 | 2.71 Mn |
| Sep 30, 2024 | 2.71 Mn |
| Jun 30, 2024 | 3.31 Mn |
| Jun 30, 2024 | 3.31 Mn |
| Mar 31, 2024 | 1.40 Mn |
| Mar 31, 2024 | 1.40 Mn |
| Dec 31, 2023 | 2.00 Mn |
| Dec 31, 2023 | 2.00 Mn |